(Q43668276)

25 November 2017

title

Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease (English)

1 reference

25 November 2017

1 reference

Müller T

1

1 reference

25 November 2017

Woitalla D

2

1 reference

25 November 2017

Hauptmann B

3

1 reference

25 November 2017

Fowler B

4

1 reference

25 November 2017

Kuhn W

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

308

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

54-56

1 reference

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Hyperhomocysteinaemia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Dopamine mercapturate can augment dopaminergic neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Non-dopaminergic drug treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Nigral endothelial dysfunction, homocysteine, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Potential Clinical and Economic Effects of Homocyst(e)ine Lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

[Combination therapy with lisuride and L-dopa in the early stages of Parkinson's disease decreases and delays the development of motor fluctuations. Long-term study over 10 years in comparison with L-dopa monotherapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901972-3

7 January 2021

10.1016/S0304-3940(01)01972-3

Identifiers

DOI

1 reference

25 November 2017

1 reference